Prasanth Reddy

1.1k total citations
28 papers, 386 citations indexed

About

Prasanth Reddy is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology. According to data from OpenAlex, Prasanth Reddy has authored 28 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 11 papers in Cancer Research and 10 papers in Oncology. Recurrent topics in Prasanth Reddy's work include Cancer Genomics and Diagnostics (10 papers), Lung Cancer Treatments and Mutations (8 papers) and Renal cell carcinoma treatment (4 papers). Prasanth Reddy is often cited by papers focused on Cancer Genomics and Diagnostics (10 papers), Lung Cancer Treatments and Mutations (8 papers) and Renal cell carcinoma treatment (4 papers). Prasanth Reddy collaborates with scholars based in United States, Italy and United Kingdom. Prasanth Reddy's co-authors include Siraj M. Ali, Alexa B. Schrock, Garrett M. Frampton, Samuel J. Klempner, Ethan S. Sokol, Rachel Anhorn, Marcia Reinhart, Shalmali Bane, David Fabrizio and Tim Peoples and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Prasanth Reddy

24 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Prasanth Reddy United States 8 205 158 117 101 88 28 386
Eriko Aimono Japan 12 192 0.9× 128 0.8× 118 1.0× 84 0.8× 71 0.8× 40 374
Pritesh Trivedi United Kingdom 11 189 0.9× 83 0.5× 88 0.8× 139 1.4× 39 0.4× 20 402
Masashi Mikubo Japan 12 213 1.0× 256 1.6× 96 0.8× 119 1.2× 63 0.7× 40 458
Jindřich Kopecký Czechia 13 227 1.1× 168 1.1× 79 0.7× 106 1.0× 89 1.0× 57 474
Paul Scorer United Kingdom 12 440 2.1× 221 1.4× 97 0.8× 79 0.8× 79 0.9× 19 553
Paloma Martín-Martorell Spain 11 279 1.4× 190 1.2× 52 0.4× 82 0.8× 37 0.4× 30 426
Marco Bono Italy 14 185 0.9× 125 0.8× 133 1.1× 189 1.9× 37 0.4× 33 446
Seiichi Fukuyama Japan 12 190 0.9× 186 1.2× 65 0.6× 76 0.8× 70 0.8× 26 422
Florian Huemer Austria 13 323 1.6× 133 0.8× 76 0.6× 114 1.1× 55 0.6× 46 502
Yasuo Hosouchi Japan 15 221 1.1× 209 1.3× 75 0.6× 140 1.4× 197 2.2× 41 580

Countries citing papers authored by Prasanth Reddy

Since Specialization
Citations

This map shows the geographic impact of Prasanth Reddy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prasanth Reddy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prasanth Reddy more than expected).

Fields of papers citing papers by Prasanth Reddy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prasanth Reddy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prasanth Reddy. The network helps show where Prasanth Reddy may publish in the future.

Co-authorship network of co-authors of Prasanth Reddy

This figure shows the co-authorship network connecting the top 25 collaborators of Prasanth Reddy. A scholar is included among the top collaborators of Prasanth Reddy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prasanth Reddy. Prasanth Reddy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Campos, Ana Bosch, Srinivas Veerla, Frida Rosengren, et al.. (2025). Genomic characterization of the HER2-enriched intrinsic molecular subtype in primary ER-positive HER2-negative breast cancer. Nature Communications. 16(1). 2208–2208. 3 indexed citations
2.
3.
Severson, Eric A., Bhagelu R. Achyut, Mary Nesline, et al.. (2023). RNA Sequencing Identifies Novel NRG1 Fusions in Solid Tumors that Lack Co-Occurring Oncogenic Drivers. Journal of Molecular Diagnostics. 25(7). 454–466. 8 indexed citations
4.
Harvey, Michael J., et al.. (2021). Budget Impact Analysis of Comprehensive Genomic Profiling in Patients With Advanced Non–Small-Cell Lung Cancer. JCO Precision Oncology. 5(5). 1611–1624. 13 indexed citations
5.
Madison, Russell W., Sumati Gupta, Yasir Y. Elamin, et al.. (2020). Urothelial cancer harbours EGFR and HER2 amplifications and exon 20 insertions. British Journal of Urology. 125(5). 739–746. 11 indexed citations
6.
Sokol, Ethan S., Natalie Danziger, Dean C. Pavlick, et al.. (2020). 107P Immune Checkpoint Inhibitor (ICPI) resistance genes STK11 and KEAP1: A comparative Comprehensive Genomic Profiling (CGP) study. Annals of Oncology. 31. S283–S284.
7.
Necchi, Andrea, Petros Grivas, Gennady Bratslavsky, et al.. (2020). Comprehensive genomic profiling (CGP) in post-systemic treatment (Post) metastatic sites (MET) and pretreatment (Pre) primary tumors (PT) of metastatic prostate cancer (mPC).. Journal of Clinical Oncology. 38(6_suppl). 175–175. 1 indexed citations
8.
Hemmerich, Amanda, Claire Edgerly, Daniel Duncan, et al.. (2020). PD-L1 expression, tumor mutational burden, and microsatellite instability status in 746 pancreas ductal adenocarcinomas.. Journal of Clinical Oncology. 38(4_suppl). 757–757. 2 indexed citations
9.
Grivas, Petros, Andrea Necchi, Gennady Bratslavsky, et al.. (2020). The emerging target KRAS G12C in genitourinary malignancies.. Journal of Clinical Oncology. 38(6_suppl). 434–434. 1 indexed citations
10.
Klempner, Samuel J., David Fabrizio, Shalmali Bane, et al.. (2019). Tumor Mutational Burden as a Predictive Biomarker for Response to Immune Checkpoint Inhibitors: A Review of Current Evidence. The Oncologist. 25(1). e147–e159. 243 indexed citations
11.
Necchi, Andrea, Gennady Bratslavsky, Oleg Shapiro, et al.. (2019). Genomic Features of Metastatic Testicular Sex Cord Stromal Tumors. European Urology Focus. 5(5). 748–755. 23 indexed citations
12.
Severson, Eric A., Ethan Sokol, Russell W. Madison, et al.. (2019). Loss of Heterozygosity of FLT3-ITD Is Common in Acute Myeloid Leukemia and May be a More Consistent Prognostic Marker Than FLT3-ITD Allele Frequency. Blood. 134(Supplement_1). 1437–1437. 1 indexed citations
13.
Tse, Julie Y., Julia A. Elvin, Jo‐Anne Vergilio, et al.. (2019). Extra-mammary Paget’s disease (EMPD) of the skin: A comprehensive genomic profiling (CGP) study.. Journal of Clinical Oncology. 37(15_suppl). 9591–9591. 1 indexed citations
14.
Ross, Jeffrey S., Ethan Sokol, Lee A. Albacker, et al.. (2019). Immunotherapy predictive biomarkers in metastatic breast cancer (MBC).. Journal of Clinical Oncology. 37(15_suppl). 1023–1023. 2 indexed citations
15.
Álvarez, Ricardo H., Eyal Meiri, Arturo Loaiza‐Bonilla, et al.. (2018). Mutational landscape of metastatic cancers discovered from prospective clinical sequencing at community practice cancer program. Annals of Oncology. 29. viii757–viii757.
16.
Necchi, Andrea, Gennady Bratslavsky, Robert J. Corona, et al.. (2018). Genomic Characterization of Testicular Germ Cell Tumors Relapsing After Chemotherapy. European Urology Focus. 6(1). 122–130. 34 indexed citations
17.
Daniel, Sugganth, Erica Gornstein, Garrett M. Frampton, et al.. (2017). BRCA1/2 reversion mutations in prostate cancer identified from clinical tissue and liquid biopsy samples.. Journal of Clinical Oncology. 35(15_suppl). 5024–5024. 1 indexed citations
18.
Gao, Xuan, et al.. (2007). Cost effectiveness of sorafenib versus best supportive care in advanced renal cell carcinoma in Canada. Journal of Clinical Oncology. 25(18_suppl). 5111–5111. 3 indexed citations
19.
Gao, Xing, Prasanth Reddy, Rahul Dhanda, et al.. (2006). Cost-effectiveness of sorafenib versus best supportive care in advanced renal cell carcinoma. Journal of Clinical Oncology. 24(18_suppl). 4604–4604. 13 indexed citations
20.
Reddy, Prasanth, et al.. (1997). Leukocyte glucose 6 phosphate dehydrogenase as prognostic indicator in ANLL and CML.. PubMed. 35(2). 155–8. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eriko Aimono Breakdown of academic impact, for papers by Pritesh Trivedi Breakdown of academic impact, for papers by Masashi Mikubo Breakdown of academic impact, for papers by Jindřich Kopecký Breakdown of academic impact, for papers by Paul Scorer Breakdown of academic impact, for papers by Paloma Martín-Martorell Breakdown of academic impact, for papers by Marco Bono Breakdown of academic impact, for papers by Seiichi Fukuyama Breakdown of academic impact, for papers by Florian Huemer Breakdown of academic impact, for papers by Yasuo Hosouchi
Rankless by CCL
2026